Researchers assessed the effect of clinical characteristics and treatment options on the prognosis of patients with rheumatoid arthritis-associated interstitial lung disease.
Researchers in China identified risk factors and initial symptoms for interstitial lung disease in primary Sjögren’s Syndrome and estimated the prevalence of ILD-pSS.
The researchers found that the rate of decline in FVC over 52 weeks was −75.9 and −178.6 mL/year with nintedanib and placebo, respectively.
Could matrix metalloproteinase-7 serve as a biomarker for predicting the course of systemic sclerosis-linked interstitial lung disease?
Researchers identified the incidence, risk factors, and outcomes of rheumatoid arthritis-associated interstitial lung disease and assessed the trends in the incidence and mortality of RA-ILD.
Researchers evaluated the association between forced vital capacity decline and hospitalization events in patients with systemic sclerosis-associated interstitial lung disease.
Are patients with fibrotic interstitial lung disease at risk of malignancy when treated with the immunomodulatory drugs MMF and AZA?
Ttransbronchial lung cryobiopsy is a less invasive method for diagnosing interstitial lung disease; how does it compare with other ILD biopsy methods?
Researchers examined maternal risks of pregnancy in the largest-to-date cohort of women with ILD secondary to an autoimmune disorder.
A review of 21 studies evaluated the long-term outcomes associated with pulmonary rehabilitation for patients with pulmonary fibrosis, including ILD.
